BRIEF published on 10/21/2026 at 17:50, 19 days 17 hours ago Median Technologies to Highlight AI Imaging at ESMO 2026 AI Technology Clinical Trials Oncology Imaging ESMO 2026 RANO 2.0
BRIEF published on 10/21/2026 at 17:50, 19 days 17 hours ago Median Technologies showcases its innovations at ESMO 2026 Artificial Intelligence Clinical Trials Medical Imaging ESMO Congress Neuro-oncology
PRESS RELEASE published on 10/21/2026 at 17:45, 19 days 17 hours ago Inside Information / Other news releases Median Technologies to showcase iCRO's central and AI-powered imaging services for oncology clinical trials at ESMO 2026. Learn about RANO 2.0 and emphysema prevalence in NSCLC patients Oncology Median Technologies ICRO ESMO 2026 RANO 2.0
BRIEF published on 10/20/2026 at 17:50, 20 days 17 hours ago Median Technologies at the 50th I-ELCAP Conference on Lung Cancer Screening AI Technology Median Technologies Lung Cancer Screening Eyonis® LCS I-ELCAP Conference
BRIEF published on 10/14/2026 at 17:50, 26 days 17 hours ago Eyonis Inc. unveils promising results from eyonis® LCS at CHEST 2026 FDA Artificial Intelligence Lung Cancer Screening Eyonis® LCS CHEST 2026
BRIEF published on 10/14/2026 at 17:50, 26 days 17 hours ago Eyonis Inc. to Showcase AI in Lung Cancer Detection at CHEST 2026 AI In Healthcare Lung Cancer Screening Eyonis® LCS CHEST 2026 FDA-Cleared Technology
PRESS RELEASE published on 10/14/2026 at 17:45, 26 days 17 hours ago Inside Information / Other news releases eyonis Inc. to present study results supporting eyonis® LCS performance claims at CHEST 2026. Key insights into AI/ML-based Software as a Medical Device for lung cancer screening. Importance of pulmonologists in adoption Eyonis® LCS CHEST 2026 Eyonis Inc. Pulmonologists AI-enabled Decision Support
BRIEF published on 09/15/2026 at 17:50, 1 month 24 days ago Median Technologies Secures Major €8.4 Million iCRO Project AI-powered Solutions Phase III Trial ICRO Project Oncology Imaging Global Pharmaceutical
PRESS RELEASE published on 09/15/2026 at 17:45, 1 month 24 days ago Inside Information / Other news releases Median Technologies secures an €8.4 million global phase III oncology imaging project, expanding its iCRO order backlog and revenue visibility. Project awarded by a leading European pharmaceutical company for brain cancer study Pharmaceutical Company Median Technologies Global Project ICRO Oncology Imaging
BRIEF published on 09/08/2026 at 19:50, 2 months 1 day ago Median Technologies: Information on voting rights and capital Share Capital Voting Rights Treasury Shares Financial Market Median Technologies
Published on 11/10/2026 at 11:00, 14 minutes ago 3D Induced Polarization Survey Identifies a Large Drill Target at East Goldfield
Published on 11/10/2026 at 08:00, 3 hours 14 minutes ago PEL 82 - QatarEnergy to Acquire 25% Participating Interest from Chevron
Published on 11/10/2026 at 02:45, 8 hours 29 minutes ago Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 12 hours 4 minutes ago Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 12 hours 14 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/10/2026 at 11:04, 10 minutes ago aap increases revenue by 2% in the third quarter of 2026 – on top of the already high prior-year level
Published on 11/10/2026 at 10:50, 24 minutes ago German R&D Tax Credits: New Administrative Instruction by Federal Ministry of Finance Tightens Documentation Requirements
Published on 11/10/2026 at 10:09, 1 hour 5 minutes ago EQS-Adhoc: Emerald Horizon AG plans to raise approximately EUR 135 million in equity by 2028 and resolves first cash capital increase
Published on 11/10/2026 at 10:08, 1 hour 5 minutes ago Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
Published on 11/10/2026 at 11:02, 11 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 4 hours 14 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 16 hours 44 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 17:35, 17 hours 39 minutes ago Disclosure of transactions in own shares from November 2 to November 6, 2026
